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SynergyThe 14-3-3 proteins are important effectors of Ser/Thr phosphorylation in eukaryotic cells. Using
mathematical modelling we investigated the roles of these proteins as effectors in signalling
pathways that involve multi-phosphorylation events. We deﬁned optimal conditions for positive
and negative cross-talk. Particularly, synergistic signal interaction was evident at very different sets
of binding afﬁnities and phosphorylation kinetics. We identiﬁed three classes of 14-3-3 targets that
all have two binding sites, but displayed synergistic interaction between converging signalling
pathways for different ranges of parameter values. Consequently, these protein targets will respond
differently to interventions that affect 14-3-3 binding afﬁnities or phosphorylation kinetics.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical
Societies. This is an open access article under the CC BY license (http://creativecommons.org/licenses/
by/4.0/).1. Introduction
Cellular adaption and decision-making rely on the communica-
tion between multiple signalling pathways. Post-translational
protein modiﬁcation on multiple sites is one important mechanism
for signal cross communication. To execute a response speciﬁc to
such multisite modiﬁcations, it often has to be ‘‘read’’ by special-
ized domains in the receiving signal transduction protein. Among
the many specialized cellular signal transduction molecules that
have been discovered during recent decades, the family of 14-3-3
proteins occupies a remarkably ubiquitous role as downstream
effectors of phosphorylation events. Essentially being soluble
dimers of single phospho-Ser/Thr binding domains, the 14-3-3
proteins are reported to bind hundreds of different cellularproteins, although there are also examples of binding to non-phos-
phorylated target proteins (for review see [1–3]). Upon binding to
their phospho-recognition site, they are reported to affect the
target protein (TP) by modulating its activity [4], interaction with
other molecules [5], intracellular localization [6] or stability [7].
Dimeric 14-3-3s are required for binding to many targets, and
several TPs like the PKCe, Cdc25B, c-Raf and Foxo4 require two
sites to be phosphorylated for high afﬁnity binding of 14-3-3
[6,8–10] (see [11] for more examples). The term ‘‘gatekeeper site’’
refers to the primary role of one phospho-site in determining 14-3-
3 binding. A secondary phosphorylation site, which in some cases
can be more divergent from the consensus sequence, can further
contribute to increased afﬁnity binding or induction of structural
changes in the TP. The latter is referred to as the ‘‘molecular anvil’’
hypothesis [12]. Multi-phosphorylation events have also been
reported to negatively regulate binding of 14-3-3 proteins, by
phosphorylation of TPs at a site close to the 14-3-3 interaction site,
thereby preventing complex-formation [10,13,14].
Context dependent signalling mechanisms can act at the level of
signalling pathways or at their downstream targets. Examples exist
for the action of 14-3-3 proteins at both levels [4,13]. We wanted
to investigate in more detail how 14-3-3 proteins may inﬂuence
signal transduction, particularly in multi-pathway communication
executed through phosphorylation at multiple sites. A mathemat-
ical modelling approach was chosen for generality, but the
Fig. 1. Inhibitory signal communication. We modelled a TP with two phosphory-
lation sites (see Fig. S4A for details on the model) where site 1 was phosphorylated
downstream of signal 1 (S1) and site 2 downstream of signal 2 (S2) (A).
Phosphorylation of site 1 (pS1-TP, r1 = kK1/kP1 = 0.1) initiated binding of 14-3-3
with high afﬁnity, which was necessary for the regulation of TP. Phosphorylation of
TP on site 2 (pS2-TP and pS1pS2-TP, r2 = kK2/kP2 = 5) inhibited any binding to 14-3-
3. Phosphorylation and dephosphorylation of the two sites were independent and
did not occur on pS1-TP bound to 14-3-3 (Fig. S4A). In (B), the amount of TP
(phosphorylated only on site 1) in complex with 14-3-3 (pS1-TP:14-3-3 complex,
fraction of total TP) is shown for varying signalling strengths of S1 and S2. A Kd of
1 nM was used for the binding of 14-3-3 to pS1-TP. The results in panel (C) were
obtained using the same model as in (B), but the Kd of 14-3-3 binding was changed
to 10 nM. The dotted circles illustrate changes in TP:14-3-3 complex expected going
from basal states of 0.1 or 1.0 nM S2, b1 or b2, respectively, to activated states a1
and a2. The signal strength from S1 is kept constant.
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interaction between 14-3-3 and TPs and experimentally derived
afﬁnity constants. We ﬁrst investigated 14-3-3 binding to TP
downstream of one signalling pathway and its regulation by phos-
phorylation kinetics and binding afﬁnities. Next, we modelled
inhibitory signal communication for 14-3-3–TP interactions where
the TPs in addition had a phosphorylation site that inhibited 14-3-
3 binding, a mechanism reported for several TPs. The capability of
dual phosphorylation site recognition of 14-3-3 proteins has been
suggested to make them functional logic AND-gates or coincidence
detectors [11]. Based on the nature of their signal output, we de-
ﬁned three functional classes of dual site 14-3-3 TPs. The inﬂuence
of phosphorylation rate kinetics of TPs and the binding afﬁnities of
14-3-3 to different phosphorylated states on the signalling
response of the different classes was then investigated. In particu-
lar, we report on conditions that gave optimal synergistic cross-
talk between the two signalling pathways, mediated by 14-3-3
interactions. These conditions varied substantially between the
three classes of 14-3-3 TPs. Our ﬁndings provide new insights into
the regulation of 14-3-3 target proteins and open up for new strat-
egies for therapeutic modiﬁcation of 14-3-3 regulated processes.
2. Materials and methods
2.1. Modelling of protein phosphorylation and 14-3-3 binding
We refer to the Supplemental text for details on the modelling
approach. The reactions were implemented in the simulation
software Copasi (v4.8) [15]. We used the LSODA algorithm for
numerical integration using an absolute tolerance of 1012.
3. Results and discussion
3.1. Signalling interaction through disrupted 14-3-3 binding
Several hundred binding partners have been reported for the
14-3-3 proteins. Most of the available 14-3-3 proteins in a cell
can therefore be expected to be bound to different target proteins.
To tackle this in our models we classiﬁed the bulk cellular 14-3-3
TPs as high and low afﬁnity binders, and used a buffered protein
interaction modelling approach for all the calculations
(Supplemental text, Fig. S1).
Starting with the simple case where only one signalling
pathway targets the TP 14-3-3 binding site, we show how different
signalling strengths (kinase/phosphatase rate ratios, rR) and Kd-val-
ues of 14-3-3 binding can modulate outputs such as complex
formation and TP phosphorylation (Figs. S2 and S3). This simple
model would apply to many 14-3-3 TPs. Multiple signalling inputs
occur when several kinases or phosphatases target the same phos-
phorylation site. As such, additional input signals will change the
rR-value, leading to altered response (Fig. S3).
Alternatively, signalling pathways may modulate the afﬁnity of
14-3-3 binding, e.g., by expression of different 14-3-3 isoforms,
modiﬁcation of 14-3-3s [16,17] or by additional modiﬁcation of
their TPs [18]. The latter mechanism has been shown for the pro-
teins Cdc25B, RGS18, Rap1GAP2 and Bad, where phosphoryla-
tion-mediated inhibition of 14-3-3 binding by direct
phosphorylation of the TP close to the 14-3-3 binding site has been
reported [10,13,14,19]. This provides a mechanism for inhibitory
signalling communication, and we investigated this mechanism
more closely where one signalling pathway downstream of signal
1 (S1) controls phosphorylation of site 1 on TP, necessary for 14-
3-3 binding (Fig. 1A, Fig. S4A). We modelled the situation where
a strong inhibitory phosphorylation was included downstream of
signal 2 (S2), that targeted a site 2 on TP and rendered it incapableof binding 14-3-3 (Fig. 1A, Fig. S4A). As the proteins reported to be
regulated by this mechanism have the inhibitory phosphorylation
site (site 2) placed adjacent to the 14-3-3 binding site (site 1),
we assumed that site 2 was unavailable for phosphorylation in
the complex between 14-3-3 and pS1-TP.
Expectedly, for high 14-3-3 binding afﬁnities (Kd = 1 nM) only
modest inhibition was obtained (Fig. 1B) even at phosphorylation
conditions favouring high phosphorylation stoichiometry on the
inhibitory site (rate constant ratio of kinase/phosphatase of site 2,
r2 = 5). This low inhibition occurred as most of the TP resided in a
complexwith 14-3-3 unavailable for inhibitory input. This is shown
inFig. S4B,where increasingS1generatedmorepS1-TP:14-3-3 com-
plex that was unresponsive to S2 signal input. A lower afﬁnity
(Kd = 10 nM) opened for more sensitive pathway communication
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phosphorylation was reciprocal for the two situations (Fig. S4B and
C). For both TPs, the strength of signalling communication depended
on thebasal signalling conditionsof the inhibitory signal and the sig-
nalling strength on site 1. Thus, a cell exposed to basal stimuli of
1 nM S2 (point b2 in Fig. 1C) is muchmore sensitive to a 10-fold in-
crease in inhibitory signal than one experiencing a basal S2 level of
0.1 nM (point b1 in Fig. 1C). We suggest that for high afﬁnity 14-3-
3 binding TPs, this mechanism for negative regulation would only
be efﬁcient if both pathways could be modiﬁed in conjunction. This
may occur automatically as the twophosphorylation sites in general
are adjacent to each other. Hence, it is expected that phosphoryla-
tion of one sitewould also affect the phosphorylation or dephospho-
rylation of the other site. However, to our knowledge the possible
interdependence has not been investigated for any of the reported
TPs that are regulated by this mechanism.
3.2. Synergistic signal communication with 14-3-3 protein interactions
Wewanted to investigate the ability of 14-3-3 proteins to medi-
ate positive signalling cross-talk through their dual phospho-site
binding capability. Several reported 14-3-3 binding proteins such
as PKCe, c-Raf, AANAT, Foxo4 and Bad have reported gatekeeper
sites, that contribute the most to 14-3-3 binding, with secondary
sites that further increase the afﬁnity of the complex [4,8–10,20].
We modelled a TP where the binding of 14-3-3 was facilitated by
phosphorylation on two sites (Fig. 2). Due to the symmetry of this
model, we considered site 1 to be a gatekeeper site (Kd1 6 Kd2), and
binding to TP phosphorylated on both site 1 and 2 (pS1pS2-TP) was
at least as strong as that for site 1 (Kd1,2 6 Kd1). Similar to the case
with single phospho-site TPs (Fig. S2), we considered different out-
put types for phospho-TP:14-3-3 complexes (Fig. 2): Class 1, the
type of phospho-TP:14-3-3 complexes where binding to any of
the two sites was sufﬁcient to mediate the biological effect (see
[11]); class 2, where the functional output of 14-3-3 associationFig. 2. Target proteins with two-site 14-3-3 binding. The model describes a TP
phosphorylated on two different phosphorylation sites by signalling pathways
modelled as described (Fig. 1 and Fig. S4). However, for this model both site 1 and 2
facilitated binding to 14-3-3 proteins. The ﬁgure shows the phosphorylation,
dephosphorylation, and 14-3-3 binding reactions for TP upon activation of S1-
pathway (blue) or S2-pathway (red). The binding of 14-3-3 to single-phosphory-
lated TP is quantiﬁed by Kd1 or Kd2, for binding to pS1-TP or pS2-TP, respectively.
Binding of 14-3-3 to double-phosphorylated TP (pS1pS2-TP) is given by Kd1,2. Three
functionally different output types were deﬁned: Class 1, total phospho-TP:14-3-3
complex, class 2, total TP phosphorylated on site 2 and class 3, 14-3-3 complex with
doubly phosphorylated TP (pS1pS2-TP:14-3-3).was increased phosphorylation of one of the sites (here shown
for site 2) [20]. Finally, we deﬁned class 3 as the type of TP where
14-3-3 binding to doubly phosphorylated TP provided the altera-
tions in bioactivity, similar to the anvil type of complex reported
for AANAT and Cdc25B [4,21].
Wemodelled ﬁrst the case with modest afﬁnity for 14-3-3 bind-
ing to TP when only one site was phosphorylated, whereas high
afﬁnity binding was included for the double-phosphorylated TP
(Kd1 = 100 nM, Kd2 = 1.0 lM, Kd1,2 = 1 nM). We also used relatively
low kinase activity relative to phosphatase (ratio for site n, rn =
kKn/kPn (Supplemental Eqs. S1 and S2), r1 = r2 = 0.1). This was ex-
pected to provide little output when only one signalling pathway
was activated, but much higher output values when both signalling
pathways were activated (Fig. 3). The steady state outputs of the
three different classes of 14-3-3 TP were then calculated for values
of signal 1 (S1) and signal 2 (S2) varying between 0.1 nM (basal)
and 1 lM (high) (half maximal activation of kinase at 10 nM, Eq.
S3). For both class 1 and 2, a low response was found (10%) when
only one signal was activated, whereas much higher activation was
found when both signalling pathways where stimulated (Fig. 3A,C).
As expected, the formed pS1pS2-TP:14-3-3 complex (class 3) had
extremely low response to single-pathway stimulations (Fig. 3E),
whereas in general the three values of the output types were quite
similar (shown as fraction of total TP).
From the surface plots it was possible to calculate the synergy
obtained by dual pathway stimulation compared to that obtained
by the two pathways alone (Fig. 3B, D and F). We chose to calculate
the ratio of the output for when both S1 and S2 are stimulated to
that of the sum of outputs obtained with single pathway stimula-
tion. We refer to this as the synergy ratio (rS), and rS will be >1 if
higher activation is obtained than could be expected from the com-
bined effect of both pathways. The rS for total phospho-TP:14-3-3
complex (Fig. 3B) and total TP site 2 phosphorylation (Fig. 3D)
was very similar (about 5, Fig. 3D), whereas that for the anvil type
was extremely high (>200; Fig. 3F) due to very low levels of 14-3-3
complex with dual-phosphorylated TP when only one signalling
pathway was activated.
3.3. Effect of binding afﬁnity and phosphorylation kinetics on
signalling pathway synergy
The similar behaviour of the three output classes led us to
investigate how changes in the value of Kd1 and r2 (phosphoryla-
tion rate ratio on site 2) affected their signalling response
(Fig. 4). First, lowering the Kd1-value to 10 nM increased 14-3-3
binding in response to S1 as expected, whereas the AND-response
(S1 and S2) was not enhanced accordingly (Fig. 4A). This led to a
strong decrease in the rS of total phospho-TP:14-3-3 (Fig. 4E),
whereas the change in TP site-2 phosphorylation was much lower
(Fig. 4B and F).
We next investigated the effect of decreasing the activity con-
stant of the protein phosphatase acting on site 2. This gave a more
robust increase in total phospho-TP:14-3-3 complex and of TP site
2 phosphorylation (Fig. 4C and D) upon stimulation with both S1
and S2. However, only the synergy for total phospho-TP:14-3-3
complex response was increased (Fig. 4E), as TP site 2 phosphory-
lation in response to S2 alone also increased considerably (Fig. 4D).
The two outputs therefore varied in their response to changes in
different parameters. The synergy ratio for the class 3 output type
varied little between the mentioned parameters (data not shown).
3.4. A comprehensive investigation of parameter variation reveals
large differences between the classes of functional outputs
The results above show that both phosphorylation kinetics and
binding afﬁnities affect the response strength and synergy
Fig. 3. Responses to multiple signalling inputs. A two-site TP (Fig. 2) was modelled using rate constant ratios (rn = kKn/kPn, rate constants for kinase and phosphatase acting on
site n) for site 1 and 2, r1 and r2, set to 0.1. Moderate to weak afﬁnity was used for singly phosphorylated TP (Kd1 = 100 nM, Kd2 = 1.0 lM) and high afﬁnity binding for double
phosphorylated TP (Kd1,2 = 1.0 nM). Panel (A) shows the fraction of total TP bound to 14-3-3 proteins (class 1 TP) for values of S1 and S2 ranging from 0.1 nM (basal stimuli) to
1.0 lM (high stimuli). The response values at S1 and S2 at basal or high stimuli were used to calculate the synergy ratio, rS, deﬁned as the ratio of signal, above basal, observed
when both S1 and S2 were high to the sum of that obtained for single stimuli of S1 and S2. (B) Shows the observed signal output of the class 1 type at basal and high S1 or S2
signal strengths. The corresponding rS-value is also shown. Panel (C) and (D) shows the response for TP class 2 where 14-3-3 increases site 2 phosphorylation, analogous to
that for (A) and (B), respectively. The signalling response for a class 3 TP for the same parameters is also shown (E) with the corresponding synergy ratio (F).
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differences between the three types of functional classes of 14-3-3
effector mechanisms. We therefore performed a comprehensive
analysis of these three output classes and how their response chan-
ged with different values of r1 and r2 (0.01–100) and Kd1, Kd2, Kd1,2
(1 nM–1 lM, Kd1,2 6 Kd1 6 Kd2), which is within the typical range of
Kd-values reported for 14-3-3 complexes (Table S2). We compared
the responses to basal and high levels of S1 and S2 and calculated
the synergy ratio (rS) for each parameter sets (Figs. S5–S11), as this
would be an important factor when considering communication
between signalling pathways.
We found that for TPs where any of the three phospho-TP:14-3-
3 complexes provide functional outputs (class 1), the synergetic
signalling response was critically dependent on lower afﬁnity
binding to monophosphorylated TP compared to that for dual-
phosphorylated TP. Increased afﬁnity of 14-3-3 binding to pS2-TP
greatly decreased the opportunity for pathway synergies, as com-
plex formation of 14-3-3 to singly phosphorylated TP competed
more strongly with that of binding to pS1pS2-TP.
It was interesting to note the narrow range of values for r1 and
r2 that allowed potent pathway synergies and how these rangesshift upon changes in afﬁnities. In particular, we noted that the
synergies for total phospho-TP:14-3-3 complex (class 1) and TP
site 2 ampliﬁcation complex type (class 2) had maxima at quite dif-
ferent ranges of r1 and r2, for Kd-values where they both showed
synergies (Fig. 5). Thus, whereas pS2-TP phosphorylation in gen-
eral showed maximal synergy at low r2 values (0.01) and medium
r1-values (1), the total phospho-TP:14-3-3 complex had maximal
synergy at medium to low r1 values (<1) and medium r2 values
(1) (Fig. 5A and B). The synergy of class 2 TPs was also muchmore
robust against values of Kd1 and Kd2 approaching that of Kd1,2. In
fact, decreasing both Kd1 and Kd2 retained much of the synergy
and led to a peculiar r2-shift where maximal synergies were now
observed at high r2-values (Fig. 5B and D). Going from a ﬂat non-
synergistic response curve at high Kd2 and Kd1 = Kd1,2, this shift oc-
curred as Kd2 decreased. At high site 2 phosphorylating conditions
(high r2) 14-3-3 complex formation could then be shifted away
from pS1-TP, which does not contribute to the functional output
of the class 2 TPs (Fig. S9).
As observed above, the synergy of pS1pS2-TP:14-3-3 formation
(class 3 TP) was high for all sets of Kd-values, but was higher at
lower values of r1 and r2 (Figs. S5, S10 and S11). Increasing the
Fig. 4. Different effects of site 1 afﬁnity and site 2 phosphorylation kinetics on signalling responses. The model from Fig. 3 was used, except that Kd1 was decreased to 10 nM
(A and B) or the phosphorylation rate ratio for site 2 (r2) was increased to 1 (C and D). The response to different inputs of S1 or S2 was then calculated for output class 1 (total
phospho-TP:14-3-3 response) (A and C) or for total TP site 2 phosphorylation (B and D). The corresponding synergy ratios were then calculated for total phospho-TP:14-3-3
complex (E) and total TP site 2 phosphorylation stoichiometry (F) for the three parameter sets, including that used in Fig. 3.
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whereas decreasing both Kd1 and Kd2 led to a narrowing of high
synergy peak giving a saddle along the line of r1 = r2. It should be
noted that the extreme synergy values observed for very low rn-
values are probably less relevant biologically as very low
phosphorylation levels of low abundance proteins will be subject
to stochastic variation, in particular in compartments conﬁned to
smaller volumes. Thus, the less spectacular, but still very strong
synergy levels (<100) are probably more biologically feasible.
3.5. Implications of parameter sensitivities for regulation of cell
signalling processes
Synergistic interactions between signalling pathways provide
opportunity for context-dependent responses, but also for ﬁltering
noise. Although several known TPs have increased binding afﬁnity
for 14-3-3 upon dual phosphorylation, this increase was
inadequate to guarantee signalling synergism (Figs. S5–S11). In
particular, to promote synergistic output of class 1 14-3-3 TPs,
binding to singly phosphorylated TP should occur with relativelylow afﬁnity, particularly for the secondary 14-3-3 binding site (site
2). In addition, the gatekeeper site should operate at low kinase/
phosphatase ratios.
The proapoptotic protein Bad is as an example of a class 1 TP.
The protein complex with 14-3-3 provides a functional output by
localising Bad in the cytosol, away from the outer mitochondrial
membrane. Phosphorylation at Ser136 and Ser112 (murine Bad
numbering) cooperate to regulate its interaction with 14-3-3 pro-
teins [20]. Synergistic signalling would be of interest to inhibit Bad
sequestration in cancer or to increase its 14-3-3 binding for neuro-
or cardioprotection. For Bad the Kd-values for binding to Ser136
and Ser112, although not quantiﬁed in isolation, seem to fulﬁl
the criteria for synergistic interaction to occur. Thus, Ser136 seems
to play a primary role in controlling 14-3-3 binding, whereas
Ser112 alone shows weaker binding and functions to further in-
crease the afﬁnity for 14-3-3 binding [20,22,23]. Additional
requirement for synergy between the two pathways is low r1
(the AKT or p70S6 kinase site) and r2  1 (Ser112, analogous to site
2, phosphorylated by MAPKAP-K1 and PAK1). Furthermore, as
discussed above (Section 3.1), the strength of inhibitory cross-talk
Fig. 5. Synergistic signalling is observed for different parameters for the three
classes of TPs. Synergy ratios > 1 were observed for all choices of Kd-values for the
anvil type of interaction (class 3). For all panels Kd1,2 was set to 1 nM, whereas Kd1
was 10 nM (A and B) or 1 nM (C and D) and Kd2 was 1.0 lM (A and B) or 10 nM (C
and D). The synergy ratio (rS) was then calculated for all sets of r1 and r2 for TPs
where the level of total phospho-TP:14-3-3 (TP of class 1) provides the functional
output (A and C) or where total level of TP site 2 phosphorylation (TP of class 2) was
important (B and D). See Figs. S5–S11 for other conditions.
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Thus, the inhibitory JNK site reported in Bad (Ser128) [19] is pre-
dicted to differentially modulate the interaction with 14-3-3
depending on the afﬁnity, i.e., if Bad is phosphorylated on Ser112
and/or Ser136. These additional requirements may explain some
of the conﬂicting observations regarding these sites [20,24,25].
Still, considerate sequence difference between human and murine
Bad, multiple isoforms, additional phosphorylation sites and other
types of modiﬁcations are all complicating factors for understand-
ing the interaction of Bad with 14-3-3s.
Numerous compounds are now available for pharmacological
intervention of 14-3-3 protein interactions that can stabilise or
destabilise complex-formation [26,27]. For more simple interac-
tions involving one pathway TPs, the binding of 14-3-3 increases
the robustness for perturbations of the upstream signalling path-
way (rR, Figs. S2 and S3). Efﬁcient signal attenuation therefore
necessitates both decreased afﬁnity for 14-3-3 and inhibition of
kinase/signalling input. For inhibitory cross talk, it may readily
be ampliﬁed or attenuated by compounds that stabilise or destabi-
lise the pS1-TP:14-3-3 complex, respectively. For synergistic signal
communication the differences in parameter robustness and opti-
mality could be used for selectivity among the TP classes or to
compensate for off-target effects. Class 3 type of TP showed highly
robust signalling output to all parameters, but can be inhibited by
inhibition of both binding afﬁnity and signalling input. For TPs of
class 1 and 2 targeted by the same signalling pathways, a conve-
nient strategy could be to decrease Kd2 and r1 to inhibit class 1
or to decrease Kd1 and increase Kd2 for class 2 TP.
4. Concluding remarks
We have investigated the quantitative requirements of signal-
ling processes involving 14-3-3 proteins. For inhibitory signalling
by phosphorylation of TPs, efﬁcient communication depends bothon basal signalling status, as well as the 14-3-3 binding afﬁnity.
Similarly, robust signalling synergy was only observed for a limited
range of afﬁnities and phosphorylation kinetics, suggesting that it
may only be observed for moderate signal strengths. Different clas-
ses of 14-3-3 TPs also responded synergistically to dual signalling
inputs within very different ranges of parameters.
The kinetic properties of various 14-3-3 TPs and their
phosphorylation are still largely uncharacterized, especially in
cells. However, for some well-studied TPs like Bad, measurements
suggest that synergetic signalling interaction is facilitated in vivo.
Our ﬁndings also suggest novel strategies for intervention. Thus,
selective modulation of different classes of 14-3-3 binding proteins
can be achieved by combining modulation of kinase activity with
compounds that directly target the binding of 14-3-3 proteins to
their TPs [26,28].
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